Pending Medicare Fee-Schedule Selection For Gene Tests Has Significant Implications – Consultant

If CMS elects to incorporate 101 new genetic testing codes into the physician payment system next year it could be a source of unpredictability for test manufacturers and labs, but selecting the laboratory fee schedule for the codes also has its pitfalls, according to a consultant in the space.

The codes were recently established to replace the current code “stacking” approach for many genetic test insurance claims to finally...